Financial statements Logispharm
Balance sheet data of LOGISPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 157 261,32 | 843 313,57 | 1 127 533,62 | 1 543 802,19 | 1 364 960,57 | 1 470 533,96 |
| A. Fixed assets | 4 950,74 | 129 948,28 | 114 824,30 | 84 639,43 | 66 550,83 | 31 895,62 |
| B. Current assets | 152 310,58 | 713 365,29 | 1 012 709,32 | 1 459 162,76 | 1 298 409,74 | 1 438 638,34 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 157 261,32 | 843 313,57 | 1 127 533,62 | 1 543 802,19 | 1 364 960,57 | 1 470 533,96 |
| A. Equity | -11 684 804,72 | -11 745 201,21 | -11 516 053,45 | -11 255 092,65 | -11 581 026,58 | -11 617 065,18 |
| B. Liabilities and provisions for liabilities | 11 842 066,04 | 12 588 514,78 | 12 643 587,07 | 12 798 894,84 | 12 945 987,15 | 13 087 599,14 |
| I. Long-term liabilities | - | - | - | 2 454 848,95 | 2 413 848,95 | 2 395 848,95 |
| II. Short-term liabilities | 11 842 066,04 | 12 588 514,78 | 12 643 587,07 | 10 344 045,89 | 10 532 138,20 | 10 691 750,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.